KURA
Kura Oncology Inc
10.80$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -126.7% | – | – | – | -173.2% | – | – | |
| – | -0.9% | +9.3% | -13.7% | +3.0% | -1.9% | +18.1% | -7.1% | -26.8% | +926.2% | -78.9% | +3.9% | – | |
| – | +1.1% | +18.8% | -1.0% | -1.3% | +3.7% | -9.1% | -11.4% | +57.8% | +3.5% | -25.9% | -2.5% | – | |
| – | +235.8% | -232.5% | – | -98.1% | +478,303.4% | -107.1% | – | -223.4% | – | -110.9% | – | – | |
| – | -20.0% | +425.0% | -81.0% | -100.0% | – | -21.5% | +399.3% | +76.1% | -9.6% | -94.5% | +412.5% | – | |
| – | +393.0% | -325.9% | – | +5.5% | -308.5% | +6.8% | – | +59.4% | -168.7% | -62.5% | – | – | |
| – | +722.6% | +21,371.6% | -98.0% | -27.6% | -63.4% | -82.3% | +260.1% | -100.0% | – | -93.9% | +2,072.5% | – | |
| – | – | -51.2% | -12.2% | +16.9% | +3,972.2% | -199.0% | – | -56.5% | +303.4% | -304.4% | – | – | |
| – | – | – | – | – | – | -126.9% | – | – | – | -174.8% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.